Learn more

GLAXO INC

Overview
  • Total Patents
    316
About

GLAXO INC has a total of 316 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, United Kingdom and South Africa. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SANOFI WINTHROP INC, LILLY CO ELI and HOFFMANN LA ROCHE.

Patent filings per year

Chart showing GLAXO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Luzzio Michael Joseph 26
#2 Myers Peter Leslie 25
#3 Evans Michael G 24
#4 Besterman Jeffrey M 22
#5 Frye Stephen Vernon 20
#6 Palson Richard Charles Julius 17
#7 Armstrong John Creighton 16
#8 Shaffer Joel E 15
#9 Wheeler Thomas N 15
#10 Feldman Paul L 14

Latest patents

Publication Filing date Title
IL113366D0 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them
GB9506678D0 Substituted 6-azacholesten-3-ones
GB9506680D0 Heterocycle-substituted pyrrolidines
GB9506282D0 Antagonists of A-1C adrenergic receptors
GB9505031D0 Nonamide inibitors of human PLA2 having a sulfone group at SN-2 position
GB9504991D0 Nonamide inhibitors of human synovial phospholipase a
GB9505007D0 Amide phospholipid-like compounds as drug absorption enhancers
GB9505006D0 Amide inhibitors of human synovial phospholipase a2
GB9423635D0 Quinazoline antagonists of alpha 1c adrenergic receptors
GB9423670D0 Antagonists of a- 1c adrenergic receptors
GB9423638D0 Antagonists of a- 1c adrenergic receptors
GB9423680D0 Antagonists of a- 1c adrenergic receptors
GB9420702D0 Heterocyclic compounds
GB9420747D0 1,5 benzodiazepine derivatives
GB9420755D0 Heterocyclic derivatives
GB9420763D0 Acetamide derivatives
GB9420783D0 Heterocyclic derivatives
GB9420748D0 1,5 benzodiazepine derivatives
GB9420699D0 Medicaments
GB9420700D0 Heterocyclic compounds